The above results revealed that the mRNA expression levels of MAP1A/1S/2/4/6/7/7D3 were significantly associated with the prognosis of NSCLC patients, and they might be utilized as possible prognostic markers in NSCLC patients. This evidence concerns the gene MAP1A and non-small cell lung carcinoma.